May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness

The month of May is recognized as Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) awareness month, a time set aside to spread awareness about these rare conditions among…

Continue Reading May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness

What Is The Best Treatment For Twin Anemia Polycythemia Sequence? A Look At The TAPS Trial

In 2006, a new, rare disease affecting monochorionic twins was identified and named. Twin Anemia Polycythemia Sequence (TAPS) changed the perception of the complications of monochorionic twins. It started redefining…

Continue Reading What Is The Best Treatment For Twin Anemia Polycythemia Sequence? A Look At The TAPS Trial

Humane Lab Testing in Dogs Leads to a Possible Cure for Leber Congenital Amaurosis (LCA) in Humans

Veterinary ophthalmologists at Pennsylvania’s Veterinarian School of Medicine found that LCA in humans mimics the same type of disease in dogs. According to a recent article in Science Daily, vision…

Continue Reading Humane Lab Testing in Dogs Leads to a Possible Cure for Leber Congenital Amaurosis (LCA) in Humans
Pamiparib for Ovarian, Fallopian, and Peritoneal Cancers Receives Conditional Approval in China
Sourced from Pixabay

Pamiparib for Ovarian, Fallopian, and Peritoneal Cancers Receives Conditional Approval in China

In China, the Conditional Approval process allows for new drugs to be marketed and developed based on an urgent and unmet need. For example, drugs which treat patients with rare…

Continue Reading Pamiparib for Ovarian, Fallopian, and Peritoneal Cancers Receives Conditional Approval in China
SHR0302 Helps Clear Severe AD, Study Says
https://unsplash.com/photos/tWTFjznQlBA

SHR0302 Helps Clear Severe AD, Study Says

According to MedPage Today, data from a preliminary study evaluating SHR0302, an investigational Janus kinase 1 (JAK1) inhibitor, showed promise for treating patients with moderate-to-severe atopic dermatitis (AD). Following treatment,…

Continue Reading SHR0302 Helps Clear Severe AD, Study Says